Adversarial attacks on a multimodal Alzheimer's disease detection system reveal complex interdependences between
Claudio Sebastian Sigvard1, José Miguel Franco-Valiente2, German Mato1,3,4
1Departamento Física y Biología Aplicadas a la Salud, Centro Atómico Bariloche, San Carlos de Bariloche, Argentina.
Biomedical Physics & Engineering Express
|July 6, 2026
Summary
Multi-modal Alzheimer's disease detection models are vulnerable to adversarial attacks. Fusing neuroimaging and clinical data creates new vulnerabilities, and imbalanced datasets risk silent modality suppression during training.
Area of Science:
- Artificial Intelligence
- Neuroscience
- Medical Imaging
Background:
- Multi-modal models integrating neuroimaging and clinical data are state-of-the-art for Alzheimer's disease detection.
- The adversarial robustness of these complex models is not well understood.
Purpose of the Study:
- To systematically investigate adversarial vulnerability in a multi-modal Alzheimer's detection model (CogniNetMM).
- To analyze vulnerability across different data fusion configurations (MRI only, clinical only, joint).
- To introduce and utilize a mean attack framework to probe decision boundary properties.
Main Methods:
- Employed Fast Gradient Sign Method and DeepFool adversarial attack algorithms.
- Evaluated three data configurations: MRI, clinical variables, and joint fusion.
- Introduced a mean attack framework to analyze fixed-direction perturbations.
Main Results:
- Identified 'modality collapse' during training, where the fusion layer suppresses MRI data, reducible by larger batch sizes and stratified sampling.
- Joint multi-modal attacks showed higher success rates than unimodal attacks, particularly with DeepFool near the decision boundary.
- The mean attack confirmed that increased vulnerability is a structural property of the fused decision boundary.
Conclusions:
- Heterogeneous data fusion in multi-modal models introduces emergent adversarial vulnerabilities not predicted by unimodal analysis.
- Standard training on imbalanced medical data may lead to silent modality suppression, impacting model reliability.
- Understanding and mitigating these emergent vulnerabilities is crucial for robust automated disease detection.
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
